I certainly can’t complain –made almost 30% on OXGN in less than two months.
I will remain on the sidelines until management fully addresses the cardiac-toxicity issue. I expect some pointed questions about this at OXGN’s CC in mid February.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”